Table 6.
Acute Toxicity of Radiotherapy
| CTC Grade ¾ | R-CHOP-21/14 With Radiotherapy (n = 268)a |
|---|---|
| Hemoglobin | 0/172 (0%) |
| Leucocytes | 5/172 (3%) |
| Platelets | 1/172 (1%) |
| Nausea | 1/192 (0·5%) |
| Vomiting | 0/198 (0%) |
| Diarrhea | 1/198 (0·5%) |
| Esophagitis/dysphagia | 7/209 (3%) |
| Constipation | 0/196 (0%) |
| Mucous membranes/mucositis | 3/201 (1%) |
| Salivary glands | 0/200 (0%) |
| Arrhythmia | 0/188 (0%) |
| Cardiac function | 0/186 (0%) |
| Dyspnea | 0/198 (0%) |
| Larynx | 1/178 (1%) |
| Hematuria | 0/172 (0%) |
| Sensory | 0/167 (0%) |
| Mood | 0/174 (0%) |
| Otitis | 0/173 (0%) |
| Keratitis | 0/173 (0%) |
| Nose/sense of smell | 0/174 (0%) |
| Skin/subcutis local | 1/189 (0·5%) |
| Infection | 2/181 (1%) |
aPatients who received radiotherapy.
CTC = common toxicity criteria; R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.